Highlights and Quick Summary
- Total liabilities for the quarter ending June 30, 2022 was $266 Million (a 1.47% increase compared to previous quarter)
- Year-over-year quarterly Total liabilities increased by 8.11%
- Annual Total liabilities for 2021 was $258 Million (a 0.2% increase from previous year)
- Annual Total liabilities for 2020 was $257 Million (a -35.6% decrease from previous year)
- Annual Total liabilities for 2019 was $399 Million (a 15.44% increase from previous year)
Visit stockrow.com/PGEN
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Total liabilities of Precigen, Inc.
Most recent Total liabilitiesof PGEN including historical data for past 10 years.Interactive Chart of Total liabilities of Precigen, Inc.
Precigen, Inc. Total liabilities for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | $265.57 | $261.73 | – | – | – |
| 2021 | $257.65 | $245.65 | $243.38 | $232.19 | $257.65 |
| 2020 | $247.41 | $277.63 | $312.17 | $317.44 | $257.13 |
| 2019 | $384.05 | $376.48 | $375.97 | $375.04 | $399.3 |
| 2018 | $337.46 | $424.97 | $258.01 | $261.54 | $345.88 |
| 2017 | $300.31 | $345.08 | $362.44 | $365.77 | $300.31 |
| 2016 | $379.82 | $397.17 | $402.93 | $287.6 | $379.82 |
| 2015 | $277.16 | $260.26 | $306.01 | $166.64 | $277.16 |
| 2014 | $166.98 | $158.66 | $112.17 | $115.91 | $166.98 |
| 2013 | $88.13 | $82.99 | $77.12 | $0.0 | $88.13 |
| 2012 | – | – | $0.0 | $0.0 | $66.54 |
| 2011 | $34.4 | – | – | – | $34.41 |
Business Profile of Precigen, Inc.
Sector: Healthcare
Industry: Biotechnology